The Clinuvel (ASX:CUV) share price is dipping today

The Clinuvel (ASX: CUV) share price is dropping today after the company released its quarterly report. We take a closer look.

| More on:
falling asx share price represented by woman making sad face

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price is falling despite positive news in its quarterly report released today.

At the time of writing, the Clinuvel share price is trading at $22.0, down 1.35%.

What's driving the Clinuvel share price today?

In its quarterly report for the period ending 31 December 2020, the biopharmaceutical company highlighted negative market conditions as a result of COVID-19 impacts.

Nonetheless, Clinuvel expanded both its commercial operation in the US and its research and development program despite the challenging conditions. The company said the expansion went ahead without the use of any equity or debt financing.

And, as hospital and medical supplies face new challenges, Clinuvel was also able to strengthen its business and balance sheet. This was underpinned by record positive cash receipts, leading to increased cash reserves.

Also during the quarter, the company progressed a number of key projects, including TGA approval of the drug Scenesse to treat adult patients with erythropoietic protoporphyria.

The commercial distribution Scenesse in the United States and Europe delivered cash receipts of $5,266,000. Net cash flow from operating activities came in at $1,293,000. This takes the rolling annual cash receipts value to $33 million, the highest since the company began commercial operations in 2016.

Cash receipts where increasing expenditures from net operating activies also increased to $4,111,000. However, the company claimed this was in order to fund future growth.

Management commentary

Commenting on the update, Clinuvel chief financial officer Darren Keamy said:

The continued performance of the group stems from our measured strategy, consistent execution, and treatment demand from both the USA and Europe, which have contributed to a new high in annual cash receipts.

Against the ongoing backdrop of economic uncertainty, and in a quarter where cash receipts are historically lower reflecting the seasonal demand, we have now been able to deliver a positive net cash result in the December quarter, the first since 2017.

About the Clinuvel share price

Despite a stream of positive company announcements, the Clinuvel share price has performed poorly over the past month, dropping 6% lower. It comes as Clinuvel remains one of the most shorted shares on the ASX.

Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Suncorp share price Businessman cheering and smiling on smartphone
Broker Notes

5 ASX 200 shares for smart investors to buy in July

Brokers think these shares could be in the buy zone ahead of the new month.

Read more »

Man with backpack spreading his arms out and soaking in the sun.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing session for investors today.

Read more »

A businessman hugs his computer and smiles.
Opinions

3 ASX 200 shares to buy and hold forever

I don't expect these stocks to go out of style anytime soon.

Read more »

American soldier in military uniform using laptop for drone controlling.
Share Market News

ASX defence shares lift amid NATO Summit decision to turbocharge spending to 5% GDP

The North Atlantic Treaty Organization (NATO) has also signed a 'milestone' agreement with Australia.

Read more »

A group of businesspeople clapping.
Broker Notes

Bell Potter names the best ASX 200 shares to buy in FY26

The broker has good things to say about these shares.

Read more »

Man on his laptop standing next to data centres.
Broker Notes

Macquarie tips 54% upside for NextDC shares

NextDC shares certainly have momentum.

Read more »

Frustrated and shocked business woman reading bad news online from phone.
Share Fallers

Why Bannerman Energy, Life360, Strike Energy, and Xero shares are tumbling today

These shares are under pressure on Thursday. But why?

Read more »

Cheerful boyfriend showing mobile phone to girlfriend in dining room. They are spending leisure time together at home and planning their financial future.
Share Fallers

Why DroneShield, Neuren, Paradigm, and Pilbara Minerals shares are roaring higher today

These shares are having a strong session on Thursday. But why?

Read more »